| 前收盘价格 | 0.050 |
| 收盘价格 | 0.050 |
| 成交量 | 1,281,428 |
| 平均成交量 (3个月) | 860,283 |
| 市值 | 54,284,368 |
| 价格/销量 (P/S) | 164.15 |
| 股市价格/股市净资产 (P/B) | 53.95 |
| 52周波幅 |
| 营业利益率 (TTM) | -1,249.72% |
| 稀释每股收益 (EPS TTM) | -0.010 |
| 季度收入增长率 (YOY) | -40.50% |
| 总债务/股东权益 (D/E MRQ) | 2.96% |
| 流动比率 (MRQ) | 3.52 |
| 营业现金流 (OCF TTM) | -4.81 M |
| 杠杆自由现金流 (LFCF TTM) | -2.75 M |
| 资产报酬率 (ROA TTM) | -91.62% |
| 股东权益报酬率 (ROE TTM) | -317.64% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (AU) | 混合的 | 混合的 |
| Medical Devices (全球的) | 混合的 | 看跌 | |
| 股票 | HERAMED FPO [HMD] | - | - |
AIStockmoo 评分
0.5
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | -4.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 4.0 |
| 平均 | 0.50 |
|
HeraMED Ltd is engaged in developing, connected pregnancy monitoring solutions for home and professional use. It has developed a foetal heartbeat monitor called HeraBEAT which is a medical-grade, clinically-validated, smart and connected Ultrasound Foetal Doppler device predominantly for use by an expectant mother to self-monitor her foetus' heart rate (FHR). It is also focused on the commercialization and deployment of its HeraCARE pregnancy monitoring solution. Geographically, the company generates a majority of its revenue from the United States of America followed by Australia and Israel. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Value |
| 内部持股比例 | 26.90% |
| 机构持股比例 | 4.43% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合